Michigan Clinical Trials

Recruiting studies in Michigan

• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)Detroit, MI
• A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
  NCT07310420PHASE1TerSera Therapeutics LLCAdvanced Breast CancerRoyal Oak, MI
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerDetroit, MI
• Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
  NCT07661056PHASE3Biohaven Therapeutics Ltd.Graves DiseaseFarmington Hills, MI
• A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
  NCT06667700PHASE3Merck Sharp & Dohme LLCCoronavirus Disease (COVID-19)Dearborn, MI
• A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
  NCT07811869PHASE3Novartis PharmaceuticalsChronic Pruritus of Unknown OriginClarkston, MI
• A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
  NCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoAnn Arbor, MI
• Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
  NCT07220187PHASE3SWOG Cancer Research NetworkRichter SyndromeBrighton, MI
• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
  NCT07335588PHASE3LEO PharmaLichen SclerosusNorthville, MI
• Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
  NCT06581432PHASE2Boehringer IngelheimSolid TumoursDetroit, MI
• A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
  NCT07412470PHASE2, PHASE3SanofiKidney Transplant RejectionAnn Arbor, MI
• A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
  NCT07128199PHASE3Taiho Oncology, Inc.Lung CancerDearborn, MI

See all 2,122 recruiting trials →

Clinical trials by Michigan metro

• Detroit
• Ann Arbor

Popular conditions in Michigan

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Michigan?

Corterve aggregates actively recruiting clinical trials with sites in Michigan from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Michigan free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Michigan?

Michigan research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.